Top Markets
Coin of the day
Allgens Medical Technology Co. Ltd. Allgens Medical Technology Co. Ltd.

Allgens Medical Technology Co. Ltd.

688613
Pozycja w akcjach #16116
Allgens Medical Technology Co. Ltd. operates as a medical device firm,... Allgens Medical Technology Co. Ltd. operates as a medical device firm, concentrating on the development and production of sophisticated biomimetic synthetic bone graft systems. These innovative solutions are engineered for global deployment in areas where both cancellous (spongy) and cortical (dense outer layer) bone tissues have been compromised. The company's diverse product portfolio includes key offerings such as BonGold, a mineralized collagen scaffold designed for bone grafting procedures; the high-performance Alligator bone marrow aspirator; and OssaNova, a mineralized collagen-based material utilized for bone filling and augmentation. These products are broadly applied across a spectrum of orthopedic and skeletal repair interventions throughout the human anatomy. Allgens Medical Technology Co. Ltd. was established in 2004 and is headquartered in Beijing, China.
Cena akcji
$2.28
Kapitalizacja rynkowa
$312.51M
Zmiana (1 dzień)
0.70%
Zmiana (1 rok)
-21.04%
Kraj
CN
Handel Allgens Medical Technology Co. Ltd. (688613)

Kategoria

Historia stopy dywidendy dla Allgens Medical Technology Co. Ltd. (688613)
Stopa dywidendy (TTM) dla Allgens Medical Technology Co. Ltd. (symbol akcji: 688613) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Allgens Medical Technology Co. Ltd. (688613) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji